AAT therapy (OncBioMune Pharmaceuticals)

N/A

Report date: 2025/03/14 16:40:25

Base Information

Drug NameAAT therapy (OncBioMune Pharmaceuticals)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionAlpha-1-antiproteinase stimulants
TargetsAlpha-1-antiproteinase
Therapy Area/IndicationsPulmonary Disease, Chronic Obstructivealpha 1-Antitrypsin Deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMexico
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTheralink Technologies
China Registration ClassN/A

Develop Information

Active CompaniesTheralink Technologies
Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic Obstructivealpha 1-Antitrypsin Deficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A